These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11851868)

  • 1. Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia.
    Sebestjen M; Zegura B; Keber I
    J Intern Med; 2002 Jan; 251(1):77-85. PubMed ID: 11851868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).
    Malik J; Melenovsky V; Wichterle D; Haas T; Simek J; Ceska R; Hradec J
    Cardiovasc Res; 2001 Nov; 52(2):290-8. PubMed ID: 11684077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors.
    Sebestjen M; Keber I; Zegura B; Simcic S; Bozic M; Fressart MM; Stegnar M
    Thromb Haemost; 2004 Nov; 92(5):1129-35. PubMed ID: 15543343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC; Wong AT; Yamashita S; Watts GF
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
    Harmer JA; Keech AC; Veillard AS; Skilton MR; Marwick TH; Watts GF; Meredith IT; Celermajer DS;
    Atherosclerosis; 2015 Sep; 242(1):295-302. PubMed ID: 26233916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.
    Paniagua JA; López-Miranda J; Pérez-Martínez P; Marín C; Vida JM; Fuentes F; Fernández de la Puebla RA; Pérez-Jiménez F
    Diabet Med; 2005 Dec; 22(12):1647-56. PubMed ID: 16401307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles.
    Wang TD; Chen WJ; Lin JW; Cheng CC; Chen MF; Lee YT
    Atherosclerosis; 2003 Oct; 170(2):315-23. PubMed ID: 14612213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
    Hamilton SJ; Chew GT; Davis TM; Watts GF
    Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
    Balletshofer BM; Goebbel S; Rittig K; Enderle M; Schmölzer I; Wascher TC; Ferenc Pap A; Westermeier T; Petzinna D; Matthaei S; Häring HU
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):324-30. PubMed ID: 15977099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction.
    Bregar U; Jug B; Keber I; Cevc M; Sebestjen M
    Heart Vessels; 2014 May; 29(3):313-9. PubMed ID: 23712600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
    J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group.
    Dujovne CA; Knopp R; Kwiterovich P; Hunninghake D; McBride TA; Poland M
    Mayo Clin Proc; 2000 Nov; 75(11):1124-32. PubMed ID: 11075741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects.
    Omori H; Nagashima H; Tsurumi Y; Takagi A; Ishizuka N; Hagiwara N; Kawana M; Kasanuki H
    Br J Clin Pharmacol; 2002 Oct; 54(4):395-9. PubMed ID: 12392587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
    Farnier M
    Am J Cardiol; 1998 Aug; 82(4B):47J-51J. PubMed ID: 9737646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D; Lowy A; Howes JB; Howes LG
    Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety.
    Stein E
    Am J Cardiol; 1998 Aug; 82(4B):40J-46J. PubMed ID: 9737645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxidation stress, insulin resistance and endothelial dysfunction during the treatment of hyperlipidaemia].
    Zeman M; Vecka M; Stopka P; Zahin M; Tvrzická E; Stanková B; Vareka T; Janíková L; Zák A
    Cas Lek Cesk; 2006; 145(12):923-8. PubMed ID: 17323614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus.
    Playford DA; Watts GF; Best JD; Burke V
    Am J Cardiol; 2002 Dec; 90(11):1254-7. PubMed ID: 12450611
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
    Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
    Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.